Philips announces EXIT-CVD project. Philips stock trades at EUR 24.01 in weekend trading

Published on 10/25/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Philips announces a five-year cardiovascular research project. Philips stock trades at EUR 24.01 in weekend trading on October 25, 2026.

Clinical research and trading schedule

On October 15, Royal Philips announced a five-year cardiovascular project involving 42 partners.
Philips stock trades in weekend trading at Lang & Schwarz at EUR 24.01 at 5:10 p.m. CEST on October 25, 2026.
The next Xetra session is scheduled for October 26, 2026.

Geometrisches Bauhaus-Poster mit Formen und Schriftzug TECH in Primärfarben — Koninklijke Philips N.V. (NL0000009538) inspiriert geometrisches Bauhaus-Poster mit Kreisen, Dreiecken und Sektor-Schriftzug TECH in Primärfarben, Illustration mit AI erstellt.

Market context: Market report AEX.

Royal Philips announced on October 15 the launch of the five-year EXIT-CVD research project, according to the company’s press release. The consortium is led by University Medical Center Groningen and Philips.

Philips stock trades in weekend trading at Lang & Schwarz at EUR 24.01 at 5:10 p.m. CEST on October 25, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Philips stock.

EXIT-CVD research project

The project brings together 42 public and private partners from 17 countries for 22 clinical studies involving more than 14,000 patients. Philips said the first patients will be enrolled in October. The project has a total budget of EUR 27.60 million and is co-funded by the European Union Innovative Health Initiative and industry partners. The studies are intended to address early detection, personalized risk assessment and advanced treatment approaches for cardiovascular disease, the company said in its announcement.